A new study shows that a topical pain medicine made of mostly natural ingredients is as good as the current standard of care in treating ankle sprain injuries in adults.
According to findings from the Traumeel in Acute Ankle Sprain Study (TAASS), which appeard in the International Journal of Clinical Practice, Traumeel, a topical pain medicine made of 14 active ingredients (12 natural), is as effective as the non-steroidal anti-inflammatory drug (NSAID) 1 % diclofenac gel, which is the current standard of care in reducing pain and improving function in adults with ankle sprain injuries.
Said Polina Karmazin, MD, Integrated Family Medicine, Voorhees, NJ:
Diclofenac gel is a current 'gold standard' therapy for ankle sprains and other types of musculoskeletal pain, but it can have serious side effects such as gastrointestinal bleeding and increased cardiovascular disease risks. These findings, from a well-controlled study (449 patients), are good news for people with ankle injuries and for the physicians who treat them because they show Traumeel, which has rare side effects, is just as effective as 1% diclofenac gel.
Topical Traumeel has previously been shown to be effective in the treatment of tendonitis, epicondylitis ("tennis elbow"), and other musculoskeletal injuries.
Said Dr. Alta Smit, Director Global Medical Affairs & Research at Heel Inc:
These results provide clinical evidence and validate Traumeel as an effective treatment option for musculoskeletal disordersThe findings from this study add to the growing evidence base that Traumeel Ointment and Gel, which other studies have shown have better tolerability and fewer side effects than NSAIDs, are as effective as NSAIDs.
TAASS was a randomized, controlled, multicenter trial that pitted Traumeel Ointment and Gel with 1% diclofenac gel for the treatment of acute ankle sprain. A total of 449 participants aged 18-40 with mild to moderate ankle sprains were randomized to receive either Traumeel ointment (n = 152), Traumeel gel (n = 150) or 1% diclofenac gel (n = 147). After seven days, Traumeel was shown to be non-inferior to 1% diclofenac gel on three self-reported scales. In other words, it proved to be just as good as the standard of care, but not better.
However, the study authors argue that the absence of the kinds of side effects that come with NSAIDS make Traumeel a more attractive choice for clinicians.